The use of AhR ligands is not limited to anti-cancer therapy but given the roles of AhR in the intestines and skin, targeting the AhR is challenging also in the treatment of inflammatory bowel disease (IBD) or skin pathologies. The gene discussed is AHR; the disease is cancer.